Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bezafibrate for Barth syndrome
ISRCTN58006579Phase 2Completed
- Sponsor
- University Hospitals Bristol and Weston NHS Foundation Trust
- Start
- Mar 2019
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of bezafibrate in Barth syndrome (BTHS) (2 arms), sponsored by University Hospitals Bristol and Weston NHS Foundation Trust. Primary endpoint: Peak oxygen consumption. Started Mar 2019; status: completed.
02
Drugs
bezafibrate
03
Conditions
Barth syndrome (BTHS)
Beyond the preview
Go deeper on ISRCTN58006579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN58006579.